Company: INSP
Filing Date: 2025-02-10
Form Type: 10-K
Source: 0001609550-25-000011
Chunk: 94

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-02-10
Form: 10-K
Item: Item 8
Chunk 94
---
 accumulated other comprehensive income balance as of both December 31, 2024 and 2023.InvestmentsOur investments are classified as available-for-sale and consisted of the following:December 31, 2024AmortizedUnrealized GrossAggregateCostGainsLossesFair ValueShort-Term:Commercial paper$19,806 $25 $— $19,831 Corporate debt securities47,226 80 (7)47,299 Certificates of deposit7,684 10 — 7,694 U.S. Treasury debt securities220,283 346 (57)220,572 Short-term investments$294,999 $461 $(64)$295,396 Long-Term:Corporate debt securities$23,915 $59 $(49)$23,925 Asset-backed securities287 — — 287 U.S. Treasury debt securities46,818 50 (85)46,783 Long-term investments$71,020 $109 $(134)$70,995 December 31, 2023AmortizedUnrealized GrossAggregateCostGainsLossesFair ValueShort-Term:Commercial paper$2,950 $1 $— $2,951 Corporate debt securities30,154 61 — 30,215 Certificates of deposit2,953 15 — 2,968 U.S. Treasury debt securities238,237 467 — 238,704 Short-term investments$274,294 $544 $— $274,838 Long-Term:Corporate debt securities$3,109 $13 $— $3,122 Asset-backed securities1,170 1 — 1,171 U.S. Treasury debt securities4,838 12 — 4,850 Long-term investments$9,117 $26 $— $9,143 

95

Table of ContentsInspire Medical Systems, Inc.Notes to Consolidated Financial Statements(Table amounts in thousands, except share and per share amounts)

The following table shows all available-for-sale investments in an unrealized loss position for which an allowance for credit losses has not been recorded and the related gross unrealized loss and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:December 31, 2024Less than 12 Months12 Months or GreaterTotalFair Value